Former Par Pharma Execs Challenge Endo Bankruptcy Clawback Suit

Former executives of Par Pharmaceutical Holdings Inc. moved to dismiss a bankruptcy trustee’s lawsuit over transfers they received prior to the opioid maker’s sale to Endo International Plc, saying the suit failed to show the payments weren’t proper.

The suit is trying to clawback “stock-based compensation” provided to nearly two dozen former Par insiders before it was acquired by Endo, they said in a Monday filing in the US Bankruptcy Court for the Southern District of New York.

The case should be dismissed because it is “devoid of any facts suggesting that any payments were excessive, not fairly valued, or ...